Chairman Michael J. Farrell - 11 Nov 2022 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Executive Officer
Signature
Michael J. Farrell, Chief Executive Officer
Issuer symbol
RMD
Transactions as of
11 Nov 2022
Net transactions value
-$1,943,303
Form type
4
Filing time
15 Nov 2022, 17:39:27 UTC
Previous filing
14 Nov 2022
Next filing
16 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Tax liability $531,200 -2,359 -0.56% $225.18 420,295 11 Nov 2022 Direct F1
transaction RMD ResMed Common Stock Tax liability $728,007 -3,233 -0.77% $225.18 417,062 11 Nov 2022 Direct F2
transaction RMD ResMed Common Stock Tax liability $684,097 -3,038 -0.73% $225.18 414,024 11 Nov 2022 Direct F3
holding RMD ResMed Common Stock 4,090 11 Nov 2022 Lisette and Michael Farrell Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/21/2019.
F2 Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2020.
F3 Disposition to issuer for tax withholding on scheduled vesting of Restricted Stock Units granted 11/18/2021.